Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone (Q40105438)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone
scientific article

    Statements

    Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone (English)
    Melissa S Bentle
    Kathryn E Reinicke
    Ying Dong
    Erik A Bey
    David A Boothman
    1 July 2007
    6936-6945

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit